Pharmaceuticals & Biotechnology Editor | 01/14/2013
Ensuring Effective Data Management and Promoting Effective Sample Control
In this presentation Peter Jackson, Managing Director, ELPRO UK, discusses why monitoring is required in biobanks, where should be monitored, specific challenges for monitoring in biobanks and features to consider when choosing a monitoring solution.
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More